This HTML5 document contains 51 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
schemahttp://schema.org/
rdfshttp://www.w3.org/2000/01/rdf-schema#
skoshttp://www.w3.org/2004/02/skos/core#
n7http://dx.doi.org/10.1080/
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n6http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q57036364
rdf:type
wikibase:Item
schema:description
article scientifique publié en 2018 wetenschappelijk artikel наукова стаття, опублікована в жовтні 2018 im Oktober 2018 veröffentlichter wissenschaftlicher Artikel scholarly article by Makio Takahashi et al published 3 October 2018 in Expert Opinion on Pharmacotherapy
p:P577
wds:Q57036364-97A7830F-EB9F-49EC-BF04-D12F71006916
wdt:P577
2018-10-03T00:00:00Z
p:P407
wds:Q57036364-87E6D70D-F5DE-4D5A-B9DC-A62A295BA794
wdt:P407
wd:Q1860
p:P2093
wds:Q57036364-7191213F-F87D-4B34-9157-B83D73B0AF25 wds:Q57036364-83D3D273-896A-4ECA-9D95-5C4FD8C91486 wds:Q57036364-3D115730-C62F-462D-8FA7-5D3143A628E5 wds:Q57036364-BB50CA3A-C869-4931-8F3A-3579802DDBF1 wds:Q57036364-8BF61DBA-C2B1-4508-ABA0-29061A837198
wdt:P2093
Mayumi Saki Makio Takahashi Naoko Asai Masaki Fujita Akihisa Mori
rdfs:label
Safety and effectiveness of istradefylline in patients with Parkinson's disease: interim analysis of a post-marketing surveillance study in Japan Safety and effectiveness of istradefylline in patients with Parkinson's disease: interim analysis of a post-marketing surveillance study in Japan
skos:prefLabel
Safety and effectiveness of istradefylline in patients with Parkinson's disease: interim analysis of a post-marketing surveillance study in Japan Safety and effectiveness of istradefylline in patients with Parkinson's disease: interim analysis of a post-marketing surveillance study in Japan
schema:name
Safety and effectiveness of istradefylline in patients with Parkinson's disease: interim analysis of a post-marketing surveillance study in Japan Safety and effectiveness of istradefylline in patients with Parkinson's disease: interim analysis of a post-marketing surveillance study in Japan
p:P1476
wds:Q57036364-4251511E-F679-4FED-B219-B6C8D378ACFA
wdt:P1476
Safety and effectiveness of istradefylline in patients with Parkinson's disease: interim analysis of a post-marketing surveillance study in Japan
p:P304
wds:Q57036364-0EC6433C-9BD9-4812-A935-8023CDB82D5F
wdt:P304
1-8
p:P31
wds:Q57036364-463E1A19-4A15-4632-9FC6-944B598258C1
wdt:P31
wd:Q13442814
p:P921
wds:Q57036364-07170F7D-EF23-4165-8F99-9FD91FD35A51 wds:Q57036364-0D59952C-ADAF-4FF8-9504-76C79F19136E
wdt:P921
wd:Q11085 wd:Q17
p:P698
wds:Q57036364-5E29B19F-8656-4C12-924C-789CB1FE00DD
wdtn:P698
n6:30281377
wdt:P698
30281377
p:P1433
wds:Q57036364-926D4CCB-9FB6-49A4-B82F-13F1368F8F27
wdt:P1433
wd:Q5421212
p:P433
wds:Q57036364-FD914DAB-04ED-4826-B326-00D9E1B6011C
p:P478
wds:Q57036364-BA07DCD1-56D7-4A67-A6DD-DE7FF99F67EA
wdt:P433
15
wdt:P478
19
p:P356
wds:Q57036364-EBB1D5DA-15BE-4E73-B2E0-661D3D5B008A
wdtn:P356
n7:14656566.2018.1518433
wdt:P356
10.1080/14656566.2018.1518433
skos:altLabel
Safety and effectiveness of istradefylline in patients with Parkinson’s disease: interim analysis of a post-marketing surveillance study in Japan
p:P4011
wds:Q57036364-6ADBA77C-4ABD-4237-9D46-3895C824C1DD
wdt:P4011
fc4459b3b11c857cbfae4910e23575fa34481343